GO:0106283 ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0106283 describes the NAD+-dependent oxidation of ursodeoxycholate to 7-oxolithocholate, a reversible reaction central to bile acid metabolism.
• The enzyme belongs to the short-chain dehydrogenase/reductase family and is found in intestinal anaerobic bacteria such as Clostridium and Peptostreptococcus species.
• 7-beta-hydroxysteroid dehydrogenases (7β-HSDH) catalyze this reaction and are key biocatalysts for the industrial production of ursodeoxycholic acid (UDCA).
• UDCA is a therapeutic bile acid used for cholestatic liver diseases, and its biosynthesis relies on efficient 7β-HSDH activity.
• Gut microbial 7β-dehydroxylation of UDCA can alter bile acid pools and influence liver disease progression, including alcoholic liver disease.
• CRISPR-based knockout, knock-in, and overexpression models enable functional dissection of 7β-HSDH genes in bile acid metabolism and drug production.
Description
GO:0106283, ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity, is a molecular function defined by the reversible NAD+-dependent oxidation of ursodeoxycholate to 7-oxolithocholate, producing NADH and a proton. This activity is catalyzed by 7-beta-hydroxysteroid dehydrogenases (7β-HSDH), enzymes that interconvert 7-hydroxy and 7-oxo bile acids and are critical for bile acid homeostasis in the gut and liver. The reaction is of broad interest because it directly impacts the availability of ursodeoxycholic acid (UDCA), a major therapeutic bile acid, and because microbial 7β-dehydroxylation can modify bile acid pools in ways that affect human health. Researchers study this activity to understand gut microbial bile acid transformation, to engineer enzymes for UDCA biosynthesis, and to explore links between bile acid metabolism and diseases such as alcoholic liver disease and cholestasis. The enzyme has been characterized in anaerobic bacteria including Peptostreptococcus productus, Clostridium absonum, Clostridium limosum, and Eubacterium species, where it participates in the 7-epimerization and dehydroxylation of bile acids. Recent protein engineering efforts have focused on improving the activity and thermostability of 7β-HSDH for industrial-scale UDCA production, highlighting the biotechnological relevance of GO:0106283.
ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity At A Glance
| GO ID | GO:0106283 |
|---|---|
| GO term | ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Catalysis of the reaction: NAD+ + ursodeoxycholate = 7-oxolithocholate + H+ + NADH. |
| Major function | NAD+-dependent oxidation of ursodeoxycholate to 7-oxolithocholate, a key step in bile acid epimerization and UDCA metabolism. |
| Cofactor | NAD+ (nicotinamide adenine dinucleotide, oxidized form) |
| Substrates | Ursodeoxycholate (UDCA); NAD+ |
| Products | 7-oxolithocholate; NADH; H+ |
| Enzyme class | Oxidoreductase; 7-beta-hydroxysteroid dehydrogenase (7β-HSDH) |
| Representative organisms | Clostridium absonum, Clostridium limosum, Peptostreptococcus productus, Eubacterium species |
What Is GO:0106283?
GO:0106283 is a molecular function term describing the catalysis of the reaction: NAD+ + ursodeoxycholate = 7-oxolithocholate + H+ + NADH. In this reversible oxidoreduction, the enzyme transfers a hydride from the 7-beta-hydroxyl group of ursodeoxycholate to NAD+, forming 7-oxolithocholate (a 7-keto bile acid), NADH, and a proton. The activity is typically associated with NAD-dependent 7-beta-hydroxysteroid dehydrogenases found in certain anaerobic gut bacteria and is distinguished from 7-alpha-HSDH activities by its stereospecificity for the 7-beta configuration.
Why Is ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity Important in Cell Biology?
GO:0106283 is important because it governs a central step in bile acid metabolism that determines the balance between ursodeoxycholic acid and its 7-oxo derivative, with direct consequences for gut microbial bile acid transformation and host physiology. The reaction is also the basis for industrial biosynthesis of UDCA, a first-line drug for cholestatic liver diseases, and improving the catalytic efficiency and stability of 7β-HSDH enzymes is an active area of protein engineering. Understanding this activity helps researchers interpret how gut microbiota modulate bile acid pools and how perturbations may contribute to liver disease, including alcoholic liver disease.
• Defines a key reversible step in bile acid epimerization between ursodeoxycholate and 7-oxolithocholate.
• Enables the industrial biosynthesis of ursodeoxycholic acid (UDCA), a major therapeutic bile acid.
• Links gut microbial metabolism to host bile acid pools and liver disease progression.
• Provides a target for enzyme engineering to improve activity and thermostability of 7β-HSDH.
• Helps distinguish 7-beta from 7-alpha hydroxysteroid dehydrogenase activities in anaerobic bacteria.
• Supports research on bile acid-induced enzyme expression in Clostridium species.
• Contributes to understanding of 7-dehydroxylation of UDCA by intestinal anaerobes such as Eubacterium species.
• Offers a biochemical marker for studying microbial bile acid transformation in the gut.
• Facilitates structure-function studies of short-chain dehydrogenases/reductases.
• Underpins biotechnological routes to UDCA that may reduce reliance on animal-derived bile acids.
Molecular Mechanism of ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
Substrate binding and stereospecific recognition
In simple terms: The enzyme grabs ursodeoxycholate and NAD+ in a precise orientation so that only the 7-beta hydroxyl is oxidized.
7-beta-hydroxysteroid dehydrogenases (7β-HSDH) bind ursodeoxycholate and NAD+ in a defined active-site geometry that positions the 7-beta hydroxyl group for hydride transfer to NAD+. The stereospecificity for the 7-beta configuration distinguishes this activity from 7-alpha-HSDH, and early characterization in Peptostreptococcus productus and Clostridium species demonstrated NAD-dependent 7-beta-hydroxysteroid dehydrogenase activity. Substrate recognition involves interactions with the bile acid steroid nucleus and the carboxylate side chain, which orient the molecule for catalysis.
Catalytic mechanism and cofactor role
In simple terms: NAD+ acts as a hydride acceptor, converting the 7-beta hydroxyl into a ketone and releasing NADH.
The reaction catalyzed by GO:0106283 is a reversible oxidoreduction in which NAD+ accepts a hydride from the 7-beta hydroxyl of ursodeoxycholate, yielding 7-oxolithocholate, NADH, and a proton. This chemistry is typical of short-chain dehydrogenase/reductase enzymes, which use a conserved catalytic triad and a Rossmann-fold nucleotide-binding domain to coordinate NAD+. The equilibrium can be driven toward either oxidation or reduction depending on cofactor ratios and substrate concentrations, which is exploited in biocatalytic UDCA synthesis.
Enzyme structure and oligomeric state
In simple terms: The enzyme is a small protein that often works as a dimer or tetramer to carry out the reaction.
7β-HSDH enzymes belong to the short-chain dehydrogenase/reductase family and typically assemble into homo-oligomeric complexes, often dimers or tetramers, that create the active site architecture. Structural and sequence-guided studies have identified key residues that influence substrate binding, cofactor preference, and catalytic efficiency, enabling rational engineering of the enzyme. The oligomeric state can affect thermostability and activity, which are critical parameters for industrial applications.
Regulation by bile acids and environmental factors
In simple terms: Bile acids themselves can induce the enzyme, and growth conditions influence how much activity is present.
Bile acid induction of 7-alpha- and 7-beta-hydroxysteroid dehydrogenases has been demonstrated in Clostridium absonum and Clostridium limosum, indicating that substrate availability can regulate enzyme expression. In the gut, the presence of ursodeoxycholate and related bile acids can influence the balance of 7-beta-dehydrogenase activity, and whole cells of Eubacterium species can 7-beta-dehydroxylate UDCA. These regulatory features link GO:0106283 to the broader dynamics of bile acid metabolism in the intestinal tract.
Reversibility and biotechnological directionality
In simple terms: The reaction can run backward to make UDCA, which is why the enzyme is useful for drug production.
Because the reaction is reversible, 7β-HSDH can be used in the reductive direction to convert 7-oxolithocholate to ursodeoxycholate, a key step in biocatalytic UDCA production. Protein engineering studies have sought to enhance both activity and thermostability, and machine-learning-guided approaches have been applied to improve NADH-dependent 7β-HSDH for economic synthesis of UDCA. These efforts highlight how understanding the catalytic mechanism of GO:0106283 translates into practical biotechnological applications.
Key Genes Involved in GO:0106283 ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
The following genes and proteins are directly associated with ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity or with the bile acid metabolic pathways in which this activity participates.
| Gene | Major Role | Research Relevance |
|---|---|---|
| 7β-HSDH (bacterial) | Catalyzes NAD+-dependent oxidation of ursodeoxycholate to 7-oxolithocholate | Core enzyme for GO:0106283; target for engineering UDCA biosynthesis |
| Clostridium absonum 7β-HSDH | Bile acid-inducible 7-beta-hydroxysteroid dehydrogenase | Model for bile acid induction of 7β-HSDH |
| Clostridium limosum 7β-HSDH | Bile acid-inducible 7-beta-hydroxysteroid dehydrogenase | Model for bile acid induction and enzyme characterization |
| Peptostreptococcus productus 7β-HSDH | NADP-dependent 7-beta-hydroxysteroid dehydrogenase | Early biochemical characterization of 7β-HSDH activity |
| Eubacterium species V.P.I. 12708 7β-HSDH | 7-beta-dehydroxylation of ursodeoxycholic acid | Whole-cell and cell-extract studies of UDCA transformation |
| NADH-dependent 7β-HSDH (engineered) | Reductive conversion of 7-oxolithocholate to UDCA | Machine-learning-guided engineering for UDCA synthesis |
| NAD+-dependent 7β-HSDH (engineered) | Oxidation of ursodeoxycholate; improved activity and thermostability | Protein engineering for efficient UDCA biosynthesis |
| NADH-dependent 7β-HSDH (novel) | Discovery of novel enzyme for UDCA biosynthesis | Sequence and structure-guided enzyme discovery |
| FXR (NR1H4) | Nuclear receptor regulating bile acid homeostasis | Links bile acid metabolism to alcoholic liver disease |
| Bile acid transporters (e.g., ASBT, NTCP) | Regulate bile acid uptake and circulation | Context for bile acid pool modulation by 7β-HSDH activity |
| Gut microbial community | Collective bile acid transformation including 7-dehydroxylation | Ecological context for GO:0106283 |
| Short-chain dehydrogenase/reductase family members | Structural scaffold for 7β-HSDH activity | Structure-function studies and engineering |
| NAD+ biosynthetic enzymes | Supply cofactor for the oxidation reaction | Cofactor availability affects reaction direction |
| NADH oxidoreductases | Regenerate NAD+ for sustained 7β-HSDH activity | Biocatalytic process optimization |
| 7-oxolithocholate reductases | Reverse reaction to produce UDCA | Biocatalytic UDCA production |
| Bile salt hydrolases | Deconjugate bile acids prior to 7β-HSDH action | Upstream step in bile acid metabolism |
| 7-alpha-HSDH | Catalyzes 7-alpha oxidation, distinct from 7-beta activity | Comparative studies of stereospecificity |
| Bile acid-responsive transcriptional regulators | Control expression of bile acid-modifying enzymes | Regulation of 7β-HSDH expression |
How Is ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity Regulated?
The expression and activity of 7-beta-hydroxysteroid dehydrogenases can be induced by bile acids, as shown in Clostridium absonum and Clostridium limosum, where bile acid exposure increased 7-alpha- and 7-beta-HSDH activities. In the gut, the availability of ursodeoxycholate and related bile acids influences the balance of 7-beta-dehydrogenase activity, and whole cells of Eubacterium species can 7-beta-dehydroxylate UDCA. Host factors such as the farnesoid X receptor (FXR) regulate bile acid homeostasis and can indirectly affect the bile acid pool available for microbial transformation, linking GO:0106283 to host-microbe metabolic regulation. Environmental conditions such as oxygen availability, pH, and cofactor (NAD+/NADH) ratios also modulate the direction and rate of the reaction.
ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| 7β-HSDH (bacterial) | Cholestatic liver disease; UDCA production | Knockout of 7β-HSDH in bacterial strains; overexpression for biocatalysis |
| FXR (NR1H4) | Alcoholic liver disease; bile acid homeostasis | FXR knockout mouse models; point mutation of FXR ligand-binding domain |
| Eubacterium 7β-HSDH | Gut microbial bile acid transformation | Knock-in of 7β-HSDH into model gut bacteria; whole-cell assays |
| Clostridium 7β-HSDH | Bile acid induction and metabolism | Bile acid induction experiments; knockout of 7β-HSDH |
| NADH-dependent 7β-HSDH (engineered) | Biotechnological UDCA synthesis | Overexpression in E. coli; directed evolution and machine-learning-guided engineering |
Cholestatic liver disease and UDCA therapy
Ursodeoxycholic acid (UDCA) is a therapeutic bile acid used for cholestatic liver diseases, and its production relies on efficient 7β-HSDH activity in the reductive direction. Understanding GO:0106283 helps researchers optimize biocatalytic routes to UDCA and interpret how microbial bile acid transformation may affect drug availability and efficacy.
Alcoholic liver disease and bile acid metabolism
Bile acids and the farnesoid X receptor (FXR) play important roles in alcoholic liver disease, and alterations in bile acid pools can influence disease progression. Microbial 7-beta-dehydroxylation of UDCA, which is related to GO:0106283, can modify the bile acid composition in the gut and may contribute to liver injury.
Gut microbial bile acid transformation and metabolic health
Intestinal anaerobic bacteria such as Eubacterium species can 7-beta-dehydroxylate ursodeoxycholic acid, altering the bile acid pool that reaches the liver and systemic circulation. This microbial activity, which is mechanistically linked to GO:0106283, may influence metabolic and inflammatory pathways relevant to liver and metabolic diseases.
From ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of 7β-HSDH alter bile acid pools? | Knockout of 7β-HSDH in bacterial strains or cell lines |
| Which residues determine substrate specificity? | Point mutation of active-site residues in 7β-HSDH |
| Can a heterologous 7β-HSDH confer UDCA production? | Knock-in of 7β-HSDH into a model bacterium or yeast |
| Where is 7β-HSDH expressed in the gut? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression increase UDCA yield? | Overexpression of 7β-HSDH in E. coli or engineered strains |
| How does bile acid induction affect enzyme levels? | Reporter knock-in or overexpression under bile acid treatment |
How to Study the ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NADH absorbance assay | NADH formation at 340 nm | Kinetic characterization of 7β-HSDH |
| HPLC | Bile acid concentrations | Quantification of UDCA and 7-oxolithocholate |
| LC-MS | Bile acid identity and abundance | Metabolite profiling in microbial cultures |
| Directed evolution | Improved enzyme variants | Engineering 7β-HSDH for UDCA synthesis |
| Machine-learning-guided engineering | Predictive enzyme design | Enhancing activity and thermostability |
| Whole-cell biotransformation | Conversion of substrates by intact cells | Studying 7-dehydroxylation in Eubacterium species |
| Bile acid induction assays | Enzyme expression changes | Regulation of 7β-HSDH in Clostridium species |
| Structural biology (crystallography/cryo-EM) | Three-dimensional enzyme structure | Structure-guided engineering of 7β-HSDH |
Enzymatic activity assays
NAD+-dependent 7-beta-hydroxysteroid dehydrogenase activity can be measured spectrophotometrically by monitoring NADH formation at 340 nm using ursodeoxycholate as substrate. These assays are foundational for characterizing GO:0106283 and for comparing wild-type and engineered enzymes.
Bile acid analysis by chromatography
High-performance liquid chromatography (HPLC) and mass spectrometry can quantify ursodeoxycholate and 7-oxolithocholate in reaction mixtures or biological samples, providing direct evidence of 7β-HSDH activity. Such methods are essential for studying bile acid transformation in microbial cultures and for optimizing biocatalytic UDCA production.
Protein engineering and directed evolution
Directed evolution, rational design, and machine-learning-guided engineering have been applied to improve the activity and thermostability of 7β-HSDH for UDCA biosynthesis. These approaches require functional screening assays that measure the conversion of 7-oxolithocholate to UDCA or the reverse oxidation reaction.
Microbial genetics and whole-cell biotransformation
Whole cells and cell extracts of anaerobic bacteria such as Eubacterium species have been used to study 7-beta-dehydroxylation of ursodeoxycholic acid, linking GO:0106283 to microbial bile acid metabolism. Bile acid induction experiments in Clostridium species provide additional tools for studying regulation of 7β-HSDH expression.
How CRISPR Can Be Used to Study GO:0106283 ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
Knockout
CRISPR knockout of 7β-HSDH genes in bacterial or cell models can abolish ursodeoxycholate 7-beta-dehydrogenase activity, enabling researchers to test the consequences for bile acid pools and UDCA metabolism. Knockout studies help establish causality between GO:0106283 and downstream phenotypes such as bile acid composition and host-microbe interactions.
Point Mutation
CRISPR-mediated point mutations can be introduced into active-site residues of 7β-HSDH to dissect substrate binding, cofactor preference, and catalytic efficiency. Such models are valuable for validating structure-function predictions and for engineering enzymes with improved properties.
Knock-in
Knock-in of 7β-HSDH or its variants into heterologous hosts can confer or enhance ursodeoxycholate 7-beta-dehydrogenase activity, providing a platform for UDCA biosynthesis and for studying the enzyme in a defined genetic background. Tagged knock-in approaches can also reveal enzyme localization and expression dynamics.
Overexpression
CRISPR activation or traditional overexpression of 7β-HSDH can increase enzyme levels and flux through the reaction, which is useful for biotechnological UDCA production and for studying the effects of elevated activity on bile acid metabolism. Overexpression models complement knockout and point-mutation studies by providing gain-of-function evidence.
How EDITGENE Supports ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity Research
Researchers studying ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity-related genes often need to determine whether a candidate gene is causally involved in bile acid transformation, UDCA production, or host-microbe metabolic interactions. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell and microbial models, enabling rigorous functional validation of genes linked to GO:0106283.
Contact EDITGENE today to design your custom CRISPR model for ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity research.
Frequently Asked Questions About ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
What is ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity?
It is a molecular function defined by GO:0106283 that catalyzes the NAD+-dependent oxidation of ursodeoxycholate to 7-oxolithocholate, producing NADH and a proton.
What is the GO ID for ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity?
The GO ID is GO:0106283, under the molecular_function ontology.
What reaction does GO:0106283 catalyze?
It catalyzes the reversible reaction: NAD+ + ursodeoxycholate = 7-oxolithocholate + H+ + NADH.
Which organisms have ursodeoxycholate 7-beta-dehydrogenase activity?
This activity has been characterized in anaerobic gut bacteria including Peptostreptococcus productus, Clostridium absonum, Clostridium limosum, and Eubacterium species.
What genes are involved in ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity?
Genes encoding 7-beta-hydroxysteroid dehydrogenases (7β-HSDH) from Clostridium, Peptostreptococcus, and Eubacterium species are directly involved, along with engineered variants for UDCA biosynthesis.
How is ursodeoxycholate 7-beta-dehydrogenase activity measured?
It is commonly measured by NADH formation at 340 nm using ursodeoxycholate as substrate, and bile acid products can be quantified by HPLC or LC-MS.
Why is ursodeoxycholate 7-beta-dehydrogenase important for UDCA production?
The enzyme catalyzes a key step in the biocatalytic synthesis of ursodeoxycholic acid, a therapeutic bile acid, and engineering efforts aim to improve its activity and thermostability.
What diseases are linked to bile acid 7-beta-dehydrogenase activity?
Alterations in bile acid metabolism, including microbial 7-beta-dehydroxylation, have been linked to cholestatic liver disease and alcoholic liver disease.
Can CRISPR be used to study ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect the function of 7β-HSDH genes and their role in bile acid metabolism.
What is the difference between 7-alpha and 7-beta hydroxysteroid dehydrogenase activity?
7-alpha and 7-beta HSDH activities differ in stereospecificity for the hydroxyl group at the 7 position of bile acids, and both have been characterized in Clostridium species.
Conclusion
GO:0106283, ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity, represents a well-defined molecular function with significant implications for bile acid metabolism, gut microbial transformation, and the biotechnological production of ursodeoxycholic acid. Understanding its catalytic mechanism, regulation, and role in disease provides a foundation for engineering improved enzymes and for exploring host-microbe interactions in liver health. CRISPR-based models offer powerful tools to dissect the genes and pathways associated with this activity, supporting both basic research and translational applications.
References
- 1. Manley S et al.. 2015. Role of farnesoid X receptor and bile acids in alcoholic liver disease.. Acta Pharm Sin B 5(2):158-67 PMID: 26579442
- 2. Edenharder R et al.. 1989. Characterization of NAD-dependent 3 alpha- and 3 beta-hydroxysteroid dehydrogenase and of NADP-dependent 7 beta-hydroxysteroid dehydrogenase from Peptostreptococcus productus.. Biochim Biophys Acta 1004(2):230-8 PMID: 2752021
- 3. MacDonald IA et al.. 1981. Bile induction of 7 alpha- and 7 beta-hydroxysteroid dehydrogenases in Clostridium absonum.. Biochim Biophys Acta 665(2):262-9 PMID: 6945134
- 4. Sutherland JD et al.. 1985. Bile acid induction of 7 alpha- and 7 beta-hydroxysteroid dehydrogenases in Clostridium limosum.. J Lipid Res 26(3):344-50 PMID: 3857290
- 5. Li Y et al.. 2024. Engineering of a hydroxysteroid dehydrogenase with simultaneous enhancement in activity and thermostability for efficient biosynthesis of ursodeoxycholic acid.. Appl Environ Microbiol 90(9):e0123724 PMID: 39207158
- 6. Huang B et al.. 2023. Sequence and structure-guided discovery of a novel NADH-dependent 7β-hydroxysteroid dehydrogenase for efficient biosynthesis of ursodeoxycholic acid.. Bioorg Chem 131:106340 PMID: 36586301
- 7. White BA et al.. 1982. 7 beta-Dehydroxylation of ursodeoxycholic acid by whole cells and cell extracts of the intestinal anaerobic bacterium, Eubacterium species V.P.I. 12708.. J Lipid Res 23(1):145-53 PMID: 7057103
- 8. Wang MQ et al.. 2023. Machine-Learning-Guided Engineering of an NADH-Dependent 7β-Hydroxysteroid Dehydrogenase for Economic Synthesis of Ursodeoxycholic Acid.. J Agric Food Chem 71(49):19672-19681 PMID: 38016669
